The Clostridium difficile Cell Wall Protein CwpV is
                    Antigenically Variable between Strains, but Exhibits Conserved
                    Aggregation-Promoting Function by Reynolds, Catherine B. et al.
The Clostridium difficile Cell Wall Protein CwpV is
Antigenically Variable between Strains, but Exhibits
Conserved Aggregation-Promoting Function
Catherine B. Reynolds, Jenny E. Emerson, Lucia de la Riva, Robert P. Fagan, Neil F. Fairweather*
Division of Cell and Molecular Biology, Centre for Molecular Microbiology and Infection, Imperial College London, London, United Kingdom
Abstract
Clostridium difficile is the main cause of antibiotic-associated diarrhea, leading to significant morbidity and mortality and
putting considerable economic pressure on healthcare systems. Current knowledge of the molecular basis of pathogenesis
is limited primarily to the activities and regulation of two major toxins. In contrast, little is known of mechanisms used in
colonization of the enteric system. C. difficile expresses a proteinaceous array on its cell surface known as the S-layer,
consisting primarily of the major S-layer protein SlpA and a family of SlpA homologues, the cell wall protein (CWP) family.
CwpV is the largest member of this family and is expressed in a phase variable manner. Here we show CwpV promotes C.
difficile aggregation, mediated by the C-terminal repetitive domain. This domain varies markedly between strains; five
distinct repeat types were identified and were shown to be antigenically distinct. Other aspects of CwpV are, however,
conserved. All CwpV types are expressed in a phase variable manner. Using targeted gene knock-out, we show that a single
site-specific recombinase RecV is required for CwpV phase variation. CwpV is post-translationally cleaved at a conserved site
leading to formation of a complex of cleavage products. The highly conserved N-terminus anchors the CwpV complex to
the cell surface. Therefore CwpV function, regulation and processing are highly conserved across C. difficile strains, whilst the
functional domain exists in at least five antigenically distinct forms. This hints at a complex evolutionary history for CwpV.
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Introduction
C. difficile is gram-positive spore forming anaerobe and a major
cause of antibiotic-associated diarrhea [1]. C. difficile infection
(CDI) often occurs in the nosocomial environment where infection
management exerts significant economic pressure on healthcare
systems. The strong association of CDI with antibiotic usage
reflects disruption of the normal gut flora allowing effective
colonization by C. difficile. Strains causing disease produce one or
two related toxins, TcdA and TcdB, which modulate the activity
of host cell Rho GTPases, destroying the integrity of the epithelial
cell barrier and inducing a variety of effects on intestinal cells [2].
Using isogenic mutants in a hamster model of infection, recent
studies have shown that toxin B plays an important role in
pathogenesis but the situation is less clear for TcdA [3,4]. C. difficile
strains causing CDI however are remarkably diverse. Despite a
high prevalence of certain strain types, for example NAP1/027 in
North America and Europe around 2005–6, no particular type
dominates and strain prevalences vary geographically and
temporally [5].
Factors expressed on the bacterial cell surface are likely to
contribute to host colonization via interactions with host tissue, the
immune system and other bacterial cells. In common with a large
number of bacterial species [6], C. difficile produces an S-layer, a
paracrystalline proteinaceous array that completely coats the
bacterial cell wall. The C. difficile S-layer is primarily composed of
two proteins, the high molecular weight S-layer protein (HMW
SLP) and the low molecular weight (LMW) SLP. These proteins
are derived from the precursor SlpA [7] through cleavage
mediated by the cysteine protease Cwp84 [8,9]. The LMW and
HMW SLPs form a stable non-covalently associated complex,
which has been analysed by small-angle X-ray scattering [10]. The
HMW SLP contains putative cell wall binding motifs (Pfam 04122)
which are thought to mediate attachment to the underlying cell
wall. The LMW SLP is highly immunogenic and variable between
strains, with over 20 distinct sequences identified to date
[11,12,13,14].
C. difficile 630 contains 28 paralogs of the HMW SLP [15].
Known as the cell wall protein (CWP) family, all members contain
two or three copies of the putative cell wall binding motif in
addition to a second unique domain that may specify function.
Transcriptomic and proteomic studies have shown several of these
proteins to be expressed in vitro [16,17]. Antibodies against some of
these proteins are found in serum of infected patients [18]
implying at least some of the CWPs are expressed in vivo during
infection and accessible to the host immune system.
In C. difficile 630 [15], CwpV is the largest member of the CWP
family and consists of three distinct domains: (1) an N-terminal
region with putative cell wall binding activity, (2) a region of
unknown function terminating in a serine-glycine-rich flexible
linker; (3) nine repeats of 120 amino acids each. We recently
described the phase variable expression of CwpV and proposed a
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between the cwpV promoter and open reading frame there is a
195 bp invertible region flanked by imperfect 21 bp inverted
repeats. In the OFF orientation this sequence adopts a stem loop
terminator, preventing formation of full-length transcripts while in
the other orientation (ON), the terminator is absent so full length
cwpV transcription proceeds and CwpV is expressed.
In this study we investigate the regulation, post-translational
processing and function of CwpV across a diverse panel of C.
difficile strains. We definitively identify the site-specific recombinase
necessary for CwpV phase variation, and show that the cwpV
switch orientation is the primary determinant of CwpV expression.
We show that the CwpV N-terminal domain is responsible for cell
wall anchoring and is well conserved across strains. In contrast, we
find high sequence variation of the C-terminal repeat sequences
across C. difficile strains with five antigenically distinct repeat types
identified. Despite this variability, both post-translational process-
ing and function of CwpV appear to be conserved across C. difficile
strains. All types of CwpV exhibit an aggregation-promoting
function, which is conferred by the variable C-terminal domain.
The implications of these findings relating to the role of CwpV in
C. difficile infection are discussed.
Results
The recombinase RecV controls expression of CwpV in C.
difficile
Previously we identified the C. difficile recV gene as a strong
candidateforthesite-specificrecombinaseresponsibleforinversionof
the cwpV DNA switch [19]. To definitively determine the role of recV
in inversion of the cwpV switch, we constructed a recV knock-out in
630Derm using ClosTron technology [20]. 630Derm (wild-type) and
four erythromycin resistant recV mutants, DrecV1-4, were confirmed
by PCR (Figure 1). To establish the orientation of the cwpV switch in
these DrecV strains, orientation-specific PCR was carried out [19]
(Figure 1B). In wild-type clones, inversion of the cwpV switch was
occurring as expected, shown by products with both primer pairs
(Figure 1C i). All four DrecV clones only amplified an OFF product
(Figure 1C ii) and were therefore designated DrecV OFF.
A plasmid encoding recV (pRecV+) was introduced into C.
difficile DrecV OFF by conjugation. The orientation of the cwpV
switch in four DrecV(pRecV+) transconjugants was tested by PCR.
In all four strains, cwpV switch inversion was observed indicating
successful complementation of the switching defect (Figure 1C iii).
RecV is a member of the phage integrase family of tyrosine
recombinases and by alignment tyrosine-176 was identified as a
putative catalytic residue. To confirm the key role of this residue,
we constructed a Tyr-Phe mutant (pRecVY176F) which was
introduced into DrecV OFF. All four DrecV(pRecVY176F) transcon-
jugants only had the cwpV switch in the OFF orientation (Figure 1C
iv). Therefore RecVY176F could not complement the DrecV OFF
phenotype confirming the key role of tyrosine-176 in RecV-
mediated inversion of the cwpV switch.
In order to isolate DrecV ON mutants, DrecV(pRecV+) was
serially subcultured without thiamphenicol selection to allow loss
of the pRecV+ plasmid. Thiamphenicol-sensitive colonies were
tested for cwpV switch orientation and all were found to contain a
single orientation, as the pRecV+ plasmid had been lost (data not
shown). Four clones, from which only the ON orientation of the
cwpV switch could be amplified, were isolated and designated DrecV
ON (Figure 1C v). The lack of inversion in these strains confirmed
the necessary role of RecV in cwpV switch inversion, and suggests
that this is the only recombinase responsible for inversion.
During the plasmid-curing process we noted two distinct colony
morphologies amongst the resulting thiamphenicol-sensitive colo-
nies. Interestingly, these were associated with the two orientations
of the cwpV switch. In Figure 1D it can be seen that DrecV OFF
colonies have the same profuse, ruffled appearance as wild-type
630 colonies, whilst DrecV ON colonies are smaller and smoother-
edged. The hypothesis that CwpV expression in a DrecV ON
background causes a smaller colony phenotype was tested (see
below).
CwpV is the major CWP on DrecV ON cells
The expression of CwpV in S-layer extracts of 630Derm (WT),
DrecV(pRecV+), DrecV(pRecVY176F), DrecV OFF and DrecV ON was
analyzed by SDS-PAGE (Figure 2A). In WT and DrecV(pRecV+)
extracts, the two cleavage products of CwpV, the ,42 kDa (N-
terminal fragment) and ,116 kDa (repeat domain) can be seen.
However, as CwpV is only expressed by the minority of ON cells,
the overall level of expression in these cultures is low. No
expression of CwpV is seen in DrecV(pRecVY176F)o rDrecV OFF
strains. Compared to WT cultures, DrecV ON strains express a
high amount of CwpV. Densitometry analysis indicated that in
DrecV ON strains, CwpV constituted 13.3% of the protein present
in the S-layer (data not shown). These findings were confirmed by
Western blot using anti-CwpVrptI (detects the ,116 kDa CwpV
repeat domain) and anti-CwpVNter (detects the ,42 kDa N-
terminal fragment) antibodies (Figures 2C). In all cases, expression
of CwpV corresponded to cwpV switch orientation (Figure 2C).
In order to assess CwpV expression at the individual cell level,
C. difficile cultures were stained using CwpVrptI antibody and
analyzed by fluorescence microscopy (Figure 2D). In the WT
culture, ,5% of cells are ON as previously reported [19]. In DrecV
OFF, expression cannot be detected on any cell. In DrecV(pRecV+)
cultures, phase variable expression of CwpV can be seen with
approximately 15% of cells expressing CwpV. The higher
proportion of CwpV-positive cells is probably due to the altered
level of RecV expression from the multi-copy plasmid, pRecV+.I n
DrecV OFF(pRecVY176F) no CwpV expression can be detected, as
expected due to a lack of switch inversion from OFF. In DrecV ON,
CwpV expression can be detected in all cells. This suggests that
Author Summary
Clostridium difficile is a bacterial pathogen that causes
antibiotic-associated diarrhea, which can be fatal. Infec-
tions often occur in healthcare facilities, where there is a
high population density of susceptible patients with many
possible routes of transmission. We currently do not know
the functions of molecules found on the surface of C.
difficile, which are likely to facilitate colonization of the
host. In this study we characterize a protein called CwpV
that is found on the surface of C. difficile. We show that
bacteria isolated from different patients have different
versions of CwpV and that the immune system’s weapons
(antibodies) against one version are useless against the
others. This suggests that CwpV may help C. difficile to
escape from our natural defenses. We have also found that
CwpV promotes aggregation of C. difficile, which may be
important for host colonization. To test these hypotheses
in the future we will use animal models to compare
genetically modified C. difficile expressing different levels
of CwpV to see if they behave differently during infection.
We hope that knowing more about CwpV will help guide
improvements in the prevention and treatment of C.
difficile.
C. difficile Aggregation-Promoting Factor CwpV
PLoS Pathogens | www.plospathogens.org 2 April 2011 | Volume 7 | Issue 4 | e1002024cwpV switch orientation is the primary determinant of CwpV
expression.
The CwpV C-terminal repeat region is variable across C.
difficile strains
Given the clinical importance of C. difficile strain diversity we
sought to determine the level of conservation of cwpV across a
variety of strains. PCR analysis of a collection of C. difficile strains
using primers specific for the 59 region of cwpV revealed the
presence of a common fragment in all strains (Figure 3Ai).
However, amplification using primers specific for the 630 repeat
region generated products only in a subset of strains (Figure 3A ii).
We have previously shown that, in these strains, the cwpV gene is
highly similar to that of 630, but differs in the number of C-
terminal repeats [19] (Figure 1A, panel vii). CDKK371 contains
six repeats and strains R8366 and Y each contain four repeats.
The repeats, termed type I, are highly similar to each other in
DNA and predicted amino acid sequence, both within any one
strain and between strains. In each strain the first repeat is more
divergent from the remaining repeated sequences, although it is
still almost identical between strains.
We were unable to amplify the 39 region of cwpV from the
remaining strains studied using primers designed against the 630
type I repeats (Figure 3A ii), consistent with a comparative genomic
microarray study using DNA probes from strain 630 which showed
that, while the 59 region of cwpV is present in each of 75 strains
studied, the 39 region was only detected in 17 strains [21]. PCR
amplification of the 39 end of the cwpV gene from two ribotype 027
strains, R20352 and R20291, was achieved using primers found to
be conserved in the 59 end of the R20352 cwpV gene and in
CD0515, the gene located downstream of cwpV in 630. The amino
acid sequence of R20352 CwpV was almost identical to 630 CwpV
from the N-terminus to the serine/glycine-rich region. However,
instead of containing repeats of 120 amino acids, these 027 strains
contained eight 79 amino acid repeat regions. PCR analysis with
primers specific for the R20352 CwpV repeats is shown (Figure 3A
iii and vii). These repeats, designated type II, were completely
distinct from type I repeats. Several 027 strains were analyzed and
Figure 1. Isolation of DrecV mutants. A. PCR confirmation of recV gene disruption using ClosTron. Primers NF1215+NF1356 flanking the ClosTron
target site in recV give a 665 bp product in 630Derm (WT). After mutagenesis, four erythromycin resistant colonies were tested and a 2839 bp product
was amplified, indicative of insertion of the group II intron into recV. These clones were designated DrecV 1-4. B. Diagrammatic representation of the
cwpV DNA switch orientation-specific PCR assay. Primers NF823+NF826 amplify a product from OFF, whilst primers NF823+NF825 amplify a product
from ON. C. Analysis of the orientation of the cwpV DNA switch in C. difficile clones by orientation PCR. (i), products for the ON and OFF orientations are
amplified from WT.(ii), all four isolatedDrecV mutants contain only the OFF orientationof thecwpV DNAswitch, therefore thesestrains arereferred to as
630DrecV OFF. (iii), complementationof 630DrecV OFF using a plasmid encoding recV (pRecV+) reconstituted the switching phenotype. (iv), a recVY176F
mutant was unable to complement DrecV OFF confirming the key role of this tyrosine residue in RecV activity. (v), DrecV(pRecV+) was serially sub-
cultured without thiamphenicol selection to enable curing of the pRecV+ plasmid. Four thiamphenicol sensitive colonies were isolated from which only
the ON orientation of the cwpV DNA switch could be amplified. These strains were therefore designated DrecV ON. D. Colony morphologies of WT and
DrecV OFF are similar, however DrecV ON exhibit a smaller, smoother-edged colony morphology.
doi:10.1371/journal.ppat.1002024.g001
C. difficile Aggregation-Promoting Factor CwpV
PLoS Pathogens | www.plospathogens.org 3 April 2011 | Volume 7 | Issue 4 | e1002024the repeats were virtually identical in sequence to one another with
the exception of the first repeat, which was slightly divergent from
the consensus but conserved between strains.
In other C. difficile strains, where the 59 region of the gene was
present but the 39 region could not be amplified, genomic DNA
was digested with AseI and then re-ligated to form circular
fragments. Following inverse PCR, sequence analysis revealed
cwpV from all strains to be practically identical to 630 cwpV
extending to the serine/glycine-rich region. The 39 region of cwpV
from strains CDKK167 and NF2029 encode six repeats of 94
amino acids distinct in sequence from types I and II, and were
designated type III. These repeats could be amplified using repeat-
specific primers (Figure 3A iv and vii). Two toxin A-B+ strains,
CDKK17 and M9, were found to have a fourth type of repeat
sequence. The first repeat is very similar to the first type III repeat,
whereas the remaining seven repeats of 98–100 amino acids are
distinct from all other repeats and were designated type IV.
Finally, non-toxic strains, AY1 and AY5, were found to have a
combination of type III repeats and a further novel 79 amino acid
repeat, designated type V. Primers designed against type IV and V
repeats reflected the sequence analysis, shown in Figure 3A v–vii.
It should be emphasized that the five types of CwpV repeat are
completely unrelated to one another. A diagrammatic represen-
tation of the eight unique CwpV protein architectures discovered
so far is shown in Figure 3B. A multiple sequence alignment of the
amino acid sequences of one repeat of each type is shown in
Figure 3C, illustrating visually how unrelated the sequences are as
no meaningful alignment can be made.
Having characterized these five repeat types, a larger collection
of strains were analyzed by PCR to determine their repeat types
(see Table 1). Our analysis of strains was not exhaustive, and it
seems possible that further CwpV repeat types may be present
amongst the considerable diversity of the C. difficile species.
However, we focused on the characterization of these five known
CwpV repeat types. For each type, a model strain was decided
upon and used to represent that type for the rest of the study. We
chose; for type I 630, for type II R20352, for type III CDKK167,
for type IV M9 (which also contains one type III repeat) and for
type V AY1 (which also contains two type III repeats). A full
multiple sequence alignment of all the repeat sequences is shown
in Figure S1.
Different CwpV repeat types are antigenically distinct
Given the completely different amino acid sequences for each
repeat type we hypothesized that the repeats may be antigenically
distinct. CwpV expression was therefore investigated using
Figure 2. CwpV expression in DrecV mutants. Overnight C. difficile cultures of WT, DrecV(pRecV+), DrecV(pRecVY176F), DrecV OFF (64) and DrecV
ON (64) were grown and analysed in the following ways: A. S-layer extracts were prepared and analysed by SDS-PAGE and Coomassie staining. B.
Western blot of S-layer extracts using anti-CwpVrptI antibody (top; 1:5000) and anti-CwpVNter antibody (bottom; 1:5000). b, repeat domain; v,N -
terminal domain. C. Orientation-specific PCR amplifying the ON and OFF orientations of the cwpV switch. D. Immunofluorescence analysis of
expression of CwpV using anti-CwpVrptI antibody. Phase and fluorescence images of one field of view are shown.
doi:10.1371/journal.ppat.1002024.g002
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domains used as antigens are indicated by black lines above the
protein cartoons in Figure 4A. S-layer extracts were prepared for
the representative strain of each type and were visualized by SDS-
PAGE (Figure 4B). The significant variation in SlpA across these
strains can be seen, as described previously [11]. Analysis by
Western blotting with anti-CwpVNter antibody reveals a single
band at ,42 kDa in each strain (Figure 4C) as would be expected
by the high level of conservation of the CwpV N-terminal domain
across strains. This confirmed expression of CwpV and localiza-
tion to the cell wall in all these strains.
S-layer extracts were then analyzed using antibodies raised
against the specific repeat types I–V. Antibodies against repeat
types I, II, IV and V recognized only their cognate strains 630,
R20352, M9 and AY1, respectively. (Figure 4D). Anti-CwpVrptIII
detects CwpV repeats in CDKK167, M9 and AY1 which all
contain at least one type III repeat. Detection of CwpV in strain
M9 with anti-CwpVrptIII is weak, this may be due to the presence
of only one type III repeat in this CwpV protein. These results
demonstrate that, as expected based on distinct amino acid
sequence, the CwpV repeat types are antigenically distinct.
Expression of all CwpV types is phase variable
Inversion of the cwpV switch has been detected in a wide variety
of strains, but phase variable expression of CwpV has only been
reported in strain 630 [19]. It therefore seemed possible that
CwpV would be expressed in a phase variable manner in strains
expressing all types of CwpV. Cultures of representative strains for
each type were stained using the appropriate anti-CwpVrpt
antibody for analysis by immunofluorescence microscopy
(Figure 5). All strains expressed CwpV in a subset of cells, ranging
from 0.1–10% of total cells, indicative of phase variable
expression. The factors determining the proportion of CwpV-
positive cells are yet to be determined, but it is clear that under
Figure 3. The CwpV C-terminal repeat region is variable across C. difficile strains. A. PCR analysis of the cwpV locus from diverse strains of
C. difficile. Primers used were specific for: i, part of the conserved N-terminal domain (NF654 and NF655) ii, a single type I repeat (NF374 and NF346)
iii, a single type II repeat (NF701 and NF702) iv, a single type III repeat (NF796 and NF797) v, a single type IV repeat (NF799 and NF800) vi, a single
type V repeat (NF878 and NF879) vii, the entire repeat region, specifically amplified for each type (NF795 with NF373, NF703, NF798, NF801 or
NF880). The cwpV type is indicated below each lane and the strain designation above. Details of the primers used are in Table S1. B. Cartoon
representation of the eight different discovered configurations of CwpV proteins. For each combination of CwpV type and number of repeats, the
repeat region from at least one strain was entirely sequenced. Black, signal sequence; grey, PF04122 cell wall anchoring domains; white, unknown
function; pink, serine/glycine-rich region; blue, type I repeats; orange, type II repeats; green, type III repeats; red, type IV repeats, purple, type V
repeats. Colour shade represents different sequence variants of a repeat type. Sequence in all strains is almost identical from the signal peptide
through to the serine/glycine-rich region. Sequences were deposited at EMBL with accession numbers FM17250-8. C. CLUSTAL multiple sequence
alignment of one repeat of each type from strains 630 (type I), 20352 (type II), CD167 (type III), M9 (type IV) and AY1 (type V).
doi:10.1371/journal.ppat.1002024.g003
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CwpV.
A conserved post-translational cleavage mechanism for
all CwpV proteins
The five different CwpV proteins from 630, R20352,
CDKK167, M9 and AY1 were modified to include a C-terminal
Strep-Tag II and expressed in C. difficile 630DcwpV using a
constitutive promoter. S-layer extracts were prepared from these
strains, designated DcwpV(pOE I-V), and analyzed by SDS-PAGE
(Figure 6A). A high level of CwpV expression can be seen for each
CwpV protein, with CwpV constituting a significant proportion of
the total S-layer extract. All five proteins are cleaved into the
,42 kDa N-terminal fragment and C- terminal fragment of
between 90 and 120 kDa, depending on their CwpV type.
Western blotting using antibodies against the N-terminal domain
detected the 42 kDa fragment in each extract and those against
the Strep-Tag II detected the 90–120 kDa C-terminal CwpV
fragment (Figure 6B). In order to determine the cleavage site for
each CwpV protein, the N-terminal sequence of each strep-tagged
C-terminal fragment was obtained. The first 5 amino acids of
every C-terminal CwpV fragment was found to be TFVNY,
unambiguously locating the cleavage site in the domain of CwpV
between the N-terminal domain and the serine/glycine rich
region, as depicted in Figure 6D. This domain is well-conserved
between CwpV proteins of different types, and indicates that the
CwpV post-translational cleavage mechanism is conserved across
CwpV types. The protease responsible for SlpA cleavage has been
Table 1. CwpV characteristics of C. difficile strains.
Strain CwpV architecture Other characteristics Reference or source
Type No. of repeats
a,b Ribotype Toxin status
CDKK371 I 6
b 001 +ve [11]
R8366 I 4
b 001 A+,B + [7]
R13537 I 6
a 001 +ve [14]
R12879 I 6
a 001 +ve [14]
R14628 I 6
a 001 +ve [14]
YI 4
b 010 A2,B 2 [11]
630 I 9
b,c 012 A+,B + [7]
CDKK959 I 4
b 053 +ve [11]
CDKK101 I 4
b 053 +ve [11]
CDKK291 I 4
b 053 +ve [11]
M120 I 4
a 078 A+,B + B. Wren
C22 I 4
a 078 A+,B + S. d’Arc
C36 I 4
a 078 A+,B + S. d’Arc
H57 I 4
a 078 A+,B + S. d’Arc
H94 I 4
a 078 A+,B + S. d’Arc
R20291 II 8
b,c 027 A+,B +; CDT+ [21]
R20352 II 8
b 027 A+,B +; CDT+ [21]
R20928 II 8
a 027 A+,B +; CDT+ [21]
CD196 II 8
a 027 A+,B +; CDT+ [41]
R12628 II 8
a 027 +ve J. Brazier
R16760 II 8
a 027 +ve J. Brazier
CDKK167 III 6
b 016 +ve C. Kelly
NF2029 III 6
a 106 A+,B + M. Wilcox
R7404 III/IV 1/7 017 A2,B + [7]
M9 III/IV 1/7
b 017 A2,B + D. Drudy
AY1 III/V 2/5
b N.D. A2,B 2 D. Gerding
AY2 III/V 2/5
b N.D. A2,B 2 D. Gerding
AY3 III/V 2/5
b N.D. A2,B 2 D. Gerding
AY4 III/V 2/5
b N.D. A2,B 2 D. Gerding
AY5 III/V 2/2
b N.D. A2,B 2 D. Gerding
B-one (B1) I 9
a N.D. A+,B + Gill Douce; [42]
The types of repeats and their number were determined by
aPCR (this study),
bDNA sequencing (this study) or
cgenome sequencing studies http://www.sanger.ac.uk/resources/downloads/bacteria/clostridium-difficile.html; N.D., not determined; +ve, toxin A+ve but toxin B
unknown.
doi:10.1371/journal.ppat.1002024.t001
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however it has been shown that Cwp84 is not required for CwpV
cleavage [8]. We have analyzed expression of CwpV in strains
containing knock-outs of either cwp84 or its paralog cwp13, and
found that neither protease is required for cleavage of CwpV (data
not shown).
All types of CwpV form a complex of the N-terminal and
C-terminal fragments
Post-translational cleavage of CwpV into two fragments is
reminiscent of post-translational cleavage of SlpA into the HMW
and LMW SLP fragments. In the case of SlpA these two fragments
form a complex allowing the HMW SLP, containing the putative
cell wall binding motifs, to anchor the LMW SLP to the
underlying cell wall [10]. We therefore reasoned that CwpV
cleavage may also be followed by complex formation to allow the
N-terminal domain, containing putative cell wall binding motifs, to
anchor the repetitive C-terminal fragment to the cell surface. To
test this hypothesis, the C-terminal repeat region from strain
DcwpV(pOEI) was purified by affinity chromatography using a
StrepTactin resin. As shown in Figure 7A, the 42 kDa and
116 kDa fragments of CwpV were co-eluted despite the presence
of the Strep-Tag II only in the larger fragment. This experiment
was then repeated with S-layer extracts from DcwpV strains over-
expressing CwpV types II–V. The complete S-layer extracts (S)
and first elutions (E) are visualized by SDS-PAGE (Figure 7B). In
all cases, both CwpV fragments co-eluted, clearly demonstrating
complex formation. As this interaction is independent of repeat
type, this strongly suggests that, as in SlpA, it is the highly
conserved regions adjacent to the cleavage site that mediate
complex formation.
The CwpV N-terminal fragment is responsible for cell wall
anchoring
The role of the N-terminal fragment of CwpV containing
putative cell binding motifs was then investigated. A truncated
form of the 630 cwpV gene which lacks the whole repetitive
sequence downstream of the serine/glycine region was created as
depicted in Figure 7C. The plasmid encoding this protein, pOE
Nter, was transferred to 630DcwpV to create DcwpV(pOENter). S-
layer extracts from wild-type, DcwpV, DcwpV(pOE I) and
DcwpV(pOENter) cultures were analysed by SDS-PAGE
(Figure 7D). The ,42 kDa N-terminal CwpV fragment is seen
in all extracts other than DcwpV and its identity was confirmed by
Western blot with anti-CwpVNter (Figure 7E). This suggests that
the N-terminal fragment of CwpV alone is sufficient for stable
association with the cell wall. The same amount of the N-terminal
CwpV fragment is seen in the DcwpV(pOEI) and DcwpV(pOENter)
S-layer extracts, showing that the truncated version of CwpV is
equally well expressed on the cell surface as the full-length CwpV
Figure 4. CwpV repeat types are antigenically distinct. A. Cross-reactivity of C. difficile S-layer extracts from strains of different CwpV type.
Recombinant CwpV domains were expressed and purified from E. coli for use as antigens. The domains used are illustrated by black lines above the
cartoons of CwpV proteins. B. S-layer extracts from C. difficile strains analysed by SDS-PAGE illustrates the variability of S-layer proteins across strains,
as previously described [11]. C. Western blot of S-layer extracts using anti-CwpVNter shows that this domain is recognized in all strains, as expected
due to high sequence conservation. D. Western blots of S-layer extracts using antibodies against CwpV repeat types I–V show that each repeat-
specific antibody only detects CwpV proteins containing at least one repeat of its own repeat type.
doi:10.1371/journal.ppat.1002024.g004
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the cell wall anchoring (CWA) fragment. This is the first reported
experimental evidence that PF04122 motifs are responsible for cell
wall anchoring.
A model for post-translational CwpV processing
The determination of the CwpV cleavage site, evidence of
complex formation by the two CwpV cleavage products, and role
of the N-terminal fragment in cell wall anchoring leads to an
overall model for post-translational CwpV processing. The three
steps involved are depicted in Figure 7F, and are compared to the
steps known to occur for SlpA processing. The first step is export
of the protein across the cell membrane and cleavage of the signal
peptide. Once on the surface the protein is cleaved (step 2) by
Cwp84 in the case of SlpA, or by an unknown mechanism in the
case of CwpV. The third step is complex formation of the cleavage
products, allowing the HMW SLP or the CwpV CWA fragment to
anchor the complex to the cell surface. All three steps appear to be
conserved amongst different CwpV types.
CwpV is an aggregation-promoting factor
As noted previously, DrecV ON strains showed a smaller,
smoother-edged colony morphology than DrecV OFF or wild-type
strains (see Figure 1D). We therefore investigated this phenome-
non in greater detail. As shown in Figure 8A, wild-type and DcwpV
strains exhibit the same disperse, ruffled colony morphology.
Over-expression of the CwpV N-terminal CWA alone in DcwpV
did not alter this colony morphology. However, over-expression of
any of the five types of full-length CwpV caused the same smaller,
smoother-edged colony morphology seen in DrecV ON mutants
(Figures 1D and 8A). These results strongly suggest that it is the
repetitive C-terminal domain of CwpV that mediates this
phenotype. In order to investigate more closely the basis of this
difference, the edges of colonies grown between glass and agar
were visualized microscopically. Detail of the colony morphology
at the cellular level can be seen in the 636magnification images
shown alongside the 16 images in Figure 8A. Wild-type, DcwpV
and DcwpV(pOENter) colonies were seen to have diffuse edges,
with directional protrusions of bacterial growth common at the
colony edge. However, DcwpV(pOEI-V) exhibited denser, straight-
er colony boundaries, with rare if any directional protrusions. The
observed macroscopic differences in colony morphology are
therefore due to altered cellular organization within bacterial
colonies.
This altered cellular organization may result from CwpV-
mediated auto-aggregation. Therefore the propensity of C. difficile
to aggregate from suspension was assessed across the panel of
strains. Over-expression of all CwpV types, except type IV, induced
aggregation of C. difficile from a liquid suspension with a starting
OD600 nm of 10 (Figure 8B). Aggregation was followed in real time,
and could be observed in tubes where aggregation was occurring
from as soon as 1 houraftersuspensionofbacteria (datanotshown).
It was found that only 630 CwpV (type I) induced aggregation of C.
difficile from suspensions with an OD600 nm of 3, while 630 CwpV
andR20352CwpV (typeII)inducedaggregationfromanOD600 nm
of 6 (data not shown). An OD600 nm as high as 40 did not lead to
type IV-mediated aggregation, nor aggregation of wild-type, DcwpV
or DcwpV(pOENter) (data not shown). Therefore it appears that the
ability to induce aggregation is highest for CwpV from 630,
followed by R20352, then CDKK167 and AY1, with no observed
propensity of M9 CwpV or the CwpV CWA fragment to induce
aggregation of C. difficile from suspension.
Discussion
We previously described the phase-variable expression of
CwpV, employing a novel transcriptional termination mechanism
[19]. Here we show that CwpV can constitute a major cell wall
protein and that it exhibits an auto-aggregation promoting
function. Surprisingly, this function is mediated by the highly
variable C-terminal repeat domain which we find in five entirely
distinct sequence types. Auto-aggregation was analyzed at both the
cellular level on solid media and within liquid culture. In vitro
colonies are organized populations of bacteria and differences in
colony morphology reflect the cellular organization of a popula-
tion [22] that can translate to important differences affecting
natural growth dynamics. Differences in the cellular organization
of colonies was clearly demonstrated by microscopy (Figure 8A)
with CwpV expression in all cells causing a denser, more randomly
packed cellular organization than the diffuse, directional patterns
of cellular packing seen at the edge of wild-type colonies. The
CwpV-mediated aggregation of C. difficile cells from suspension
strongly suggests that CwpV has a direct aggregation-promoting
function rather than a direct effect on motility. In fact the motility
of strains in soft agar was found to be similar, regardless of whether
or not they expressed CwpV (see Figure S2 and Text S1).
Propensities of different CwpV types to cause aggregation
varied, as observed by the different starting densities of suspensions
Figure 5. Expression of all CwpV types is phase variable.
Overnight C. difficile cultures of each strain were stained with the
appropriate anti-CwpVrpt antibody (630, rptI; R2035, rptII; CDKK167,
rptIII; M9, rptIV; AY1, rptV) then with anti-rabbit rhodamine red-X. From
left to right; phase image, fluorescent image, overlay.
doi:10.1371/journal.ppat.1002024.g005
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aggregation. This is likely to reflect different affinities of the
different CwpV proteins for their ligand(s). The lack of an
observable aggregation phenotype due to type IV repeats may be
explained by a weaker affinity between this repeat type and its
ligand, however the observed colony morphology phenotype does
suggest that it carries out the same general function as the other
types. Functional interactions between CwpV and motility factors,
such as type IV pili and flagella, are worthy of further study.
Indeed, the diffuse directional organization of wild-type colony
edges seen in this study is reminiscent of twitching motility
mediated by type IV pili in Clostridium perfringens [23]. C. difficile
does have type IV pili clusters, which are conserved across strains
[24]. Type IV pili may therefore be involved in the cellular
organization of wild-type colonies grown on solid surfaces
observed here. Auto-aggregative proteins have been shown to
play roles in biofilm formation [25,26,27]. No studies on C. difficile
biofilms have been reported, and in our experience C. difficile does
not exhibit significant biofilm formation on abiotic surfaces (data
not shown). However in infected mice large aggregates of C. difficile
cells, described as exaggerated mats, were reported to be
associated with regions of severe inflammation [28]. This
description is indicative of a biofilm-like growth of C. difficile
during infection. Multispecies biofilms in the human GI tract have
been observed [29] and C. difficile is likely to require factors that
promote appropriate intra- and inter-species interactions to
colonize the gut. CwpV may play important roles in this process.
Aside from its aggregation-promoting function CwpV may have
other functions. We investigated bacterial adhesion to Caco-2
cells, but no significant difference in adhesion was caused by
CwpV expression (data not shown). Further work is required to
assess whether CwpV expression affects colonization levels in vivo,
and if so whether this is directly due to its aggregation-promoting
activity. Understanding the roles of CwpV during in vivo infection
is a priority and will be addressed using the isogenic mutants
described in this study. Established animal models of infection
focus more on the acute stage of C. difficile infection, rather than
colonization [30]. However, recent developments of animal
models better suited to studying the roles of C. difficile genes likely
to be involved in colonization, such as CwpV, have been described
[28,31] that will facilitate our future investigation. The phase-
variable expression of CwpV may be highly relevant to any in vivo
role; its expression in a sub-set of cells as a contingency may be
beneficial to the survival of the population as a whole.
The variation of CwpV repeat sequences uncovered in this
study is extensive, with strains expressing one or two of five
antigenically distinct types encoded by unrelated sequences. The
lack of sequence homology between repeat types suggests
acquisition by horizontal gene transfer. Any known mechanism
of chromosomal sequence acquisition; homologous recombination,
illegitimate recombination or additive integration could account
for introduction of these sequences to the C. difficile chromosome
[32]. However, without knowing the origin of these sequences, the
mechanisms of transfer to C. difficile and incorporation into the
genome are unclear. Human microbiome sequencing may shed
light on the origins of CwpV sequences. It would seem that CwpV
type exchange is occurring at a low frequency, as all strains tested
from within one ribotype contain the same CwpV type. Current
Figure 6. A conserved post-translational cleavage site for all CwpV proteins. A. S-layer extracts from 630DcwpV and 630DcwpV containing
plasmids pOEI-V that over-express CwpV types I-V with a C-terminal Strep-tag were analysed by SDS-PAGE gel and Coomassie staining. b, repeat
domain; v, N-terminal domain. B. Western blots of S-layer extracts using anti-Strep tag antibody detects the Strep-tagged CwpV C-terminal repeat
domain. C. Western blots of S-layer extracts using anti-CwpVNter antibody detects the CwpV N-terminal domain. D. N-terminal sequencing of all
strep-tagged CwpV C-termini yielded the sequence TFVNY, revealing the conserved cleavage site for all CwpV types. As illustrated, the cleavage site
(*) is located between the cell wall anchoring domains (grey) and the serine/glycine-rich region (pink).
doi:10.1371/journal.ppat.1002024.g006
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PLoS Pathogens | www.plospathogens.org 9 April 2011 | Volume 7 | Issue 4 | e1002024Figure 7. CwpV cleavage products form a complex that is anchored to the cell wall by the N-terminal domain. A. Streptactin binding/
elution assay of a 630DcwpV(pOE I) S-layer extract analysed by SDS-PAGE. Lanes 1, S-layer extract (S); 2, Streptactin resin flow through; 3–7, washes;
8–12, elutions (E). The ,42 kDa CwpV N-terminal fragment (v) and ,116 kDa CwpV C-terminal strep-tagged fragment (b) are indicated. B. S-layer
extracts (S) and first elution (E) from 630DcwpV(pOEI-V) streptactin binding/elution assays. In each lane E, the CwpV N-terminal (v) and C-terminal (b)
fragments can be seen. C. Illustration of full length CwpV (pOEI, top) and the truncated version of CwpV (pOENter; bottom). D. Expression of
truncated CwpV in DcwpV visualized by SDS-PAGE, compared to WT 630, 630DcwpV and 630DcwpV(pOEI). Truncation of CwpV does not affect the
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strains is limited [21,33]. However current data suggests a single
clade is associated with one CwpV type; the HY (027) clade
associates with type II CwpV, the A-B+ clade with type IV CwpV,
the HA2 (078) and HA1 clades with type I CwpV. The locations of
strains expressing type III and V CwpV within this phylogenetic
tree of C. difficile are not yet known. As more C. difficile strains are
sequenced and our understanding of evolutionary relationships
between strains improves, it will become clearer as to when
different CwpV types were acquired, and whether single or
multiple independent acquisition events for each type have
occurred. Host immune pressure is one possible selection that
could promote CwpV variability, as one key difference between
CwpV types is their antigenicity. Antigenic variability is also seen
in the C. difficile surface proteins SlpA and Cwp66 [34]. Variation
in surface proteins may also be involved in competition between
different C. difficile strains or in resistance to bacteriophages.
Apart from the marked diversity in CwpV repeat sequences,
other aspects of CwpV are remarkably conserved. Expression of all
types of CwpV is phase variable suggesting that this complex
regulatory mechanism, involving the conserved cwpV switch and
the RecV recombinase, is important for optimal function of
Figure 8. CwpV is an aggregation-promoting factor. A. Colony morphology caused by CwpV over-expression in C. difficile. 630, 630DcwpV, and
630DcwpV(pOENter) exhibit the same colony morphology. 630DcwpV(pOEI-V) all exhibit a smaller, smoother-edged colony morphology. These
differences can be seen at the macroscopic level, shown by the 16photographs on the left for each strain. Differences at the colony boundaries can
be seen microscopically shown by the 636images on the right for each strain. B. Aggregation of C. difficile in suspension (starting OD600nm of 10) was
observed in suspensions of DcwpV(pOEI, II, III and V), but not by 630, DcwpV, DcwpV(pOENter) or DcwpV (pOEIV).
doi:10.1371/journal.ppat.1002024.g008
expression of the CwpV N-terminal fragment in the C. difficile S-layer. E. Western blot analysis of the S-layer extracts from 630, 630DcwpV,
630DcwpV(pOEI) and 630DcwpV(pOENter) using anti-CwpVNter antibody. F. Cartoon representation of the overall model for post-translational CwpV
processing and incorporation into the S-layer with analogy to SlpA processing. + 6, cleavage sites. Step 1, signal peptide (SP) cleavage and transport
across the cell membrane. Step 2, cleavage of protein. SlpA is cleaved by Cwp84 into the LMW and HMW SLP. The protease responsible for CwpV
cleavage is currently unknown. Step 3, formation of a complex of the products of cleavage, anchoring both products to the cell surface.
doi:10.1371/journal.ppat.1002024.g007
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reported to be involved in numerous processes including immune
evasion and colonization [35]. Given the sequence variability and
aggregation-promoting function of CwpV, several explanations
behind its phase variable regulation can be suggested. However,
investigation into CwpV expression during in vivo infection is likely
to shed most light on the importance of CwpV phase variability.
Conserved post-translational processing of CwpV and formation
of a CWA-repeat domain complex again suggests that these
processes are important for optimal CwpV expression and function.
To date we only observe complex formation in cell wall proteins
CwpV and SlpA, with all other CWPs studied (e.g. Cwp84, Cwp66,
Cwp2) being presented on the surface without post-translational
cleavage between the CWA and functional domains. An uniden-
tified protease could mediatecleavage of CwpV,or it could undergo
non-enzymatic auto-processing as reported for a number of protein
families [36,37]. Uncleaved SlpA is poorly tolerated on the cell wall,
and is found in large quantities in the culture supernatant of a
Dcwp84 mutant [9]. SlpA monomers once cleaved must interact on
the cell surface to form a two-dimensional array. Expression of
CwpV does not appear to disrupt the integrity of the S-layer and, by
analogy, it seems likely that cleavage of CwpV is important for its
stable incorporation into the S-layer. Given the high proportion of
the total S-layer accounted for by CwpV in DrecV ON strains, it
seems likely that CwpV interacts positively with other S-layer
proteins to maintain the integrity of S-layer packing.
Our finding that the CwpV CWA domain is responsible for
anchoring of the CwpV C-terminal domain to the underlying cell
wall is the first direct evidence of the function of Pf04122 domains.
These domains are also present in the HMW SLP of the C. difficile
S-layer where the presumably mediate a similar role. They are also
found in a large variety of Gram-positive bacteria and some
Archaea, where they presumably fulfill a similar function of
anchoring cell wall proteins to the underlying structure. This then
adds to the diversity of mechanisms used by Gram-positive
bacteria to anchor and display cell wall proteins [38,39].
Phylogenetic studies [21] show that outbreak-causing strains of C.
difficile have emerged independently from multiple lineages,
indicating that virulent strains can emerge from across the diversity
of the species, rather than being confined to a specific pathogenic
lineage.Thissuggeststhatcertain geneticelementscommontoallC.
difficile strains underlie virulence. It is likely that the incidences of
different lineages causing disease are dynamic, and we cannot
predict which lineages may cause future outbreaks. Therefore
understanding the common features of C. difficile as an ancient
species is important, as in order for intervention strategies to be
successful in the long-term they must target the full diversity of C.
difficile strains, rather than specific lineages. CwpV appears to be a
core component of C. difficile, including its phase variable regulation
controlled by RecV, post-translational processing mechanism, and
aggregation-promoting function. This highlights the importance of
CwpV to C. difficile survival throughout evolution of this diverse
species. Despite this conservation CwpV appears to have been
under positive selection for antigenic variability. Further investiga-
tion into the roles of CwpV in the C. difficile life cycle may teach us a
lot about what makes C. difficile a successful pathogen, and provide
opportunities for new intervention strategies.
Materials and Methods
Bacterial strains and growth conditions
The C. difficile strains characterised for CwpV type in this study
are described in Table 1. C. difficile laboratory-generated mutant
and recombinant-plasmid containing strains used in this study are
described in Table S3. C. difficile was routinely cultured on blood
agar base II (Oxoid) supplemented with 7% horse blood (TCS
Biosciences), brain-heart infusion (BHI) agar (Oxoid) or in BHI
broth (Oxoid). Cultures were grown in an anaerobic cabinet (Don
Whitley Scientific) at 37uC in an atmosphere of 10% CO2, 10%
H2 and 80% N2. C. difficile strains containing recombinant
plasmids were grown under thiamphenicol selection. Commercial
chemically competent TOP10 E. coli cells (Invitrogen) were used
for cloning and recombinant plasmid maintenance. Recombinant
expression of CwpV fragments was carried out in Rosetta E. coli
cells (Novagen). E. coli strains were routinely grown at 37uC on LB-
agar plates or in LB liquid culture in the presence of selective
antibiotics where appropriate to any transformed plasmid.
DNA manipulations
DNA manipulations were carried out according to standard
techniques. C. difficile genomic DNA for use in cloning and PCR
analysis was prepared as described previously [19]. Polymerase
chain reactions (PCR) used KOD (Novagen), Expand Long-
Template Polymerase (Roche Diagnostics) or Taq polymerase
(Sigma) in accordance with the manufacturers’ protocols using
primers detailed in Table S1.
Production of recombinant plasmids
In order to produce a C. difficile 630Derm knock out of recV,a
retargeted ClosTron vector was designed using the intron design
tool www.clostron.com. The top-scored target site in recV was
selected (424/425s) and the intron targeting region required was
commercially synthesized and cloned into pMTL007C-E2 (DNA
2.0) to generate a plasmid pLRP028. For complementation of the
DrecV mutant, the recV gene from C. difficile 630 was amplified using
primers NF1357 and NF1358 and cloned using SacI and BamHI
into a C. difficile plasmid expression vector, based on the pMTL960
replicon [19,40] to generate pCBR113 (pRecV+). Inverse PCR
with primers NF1411 and NF1412, using pCBR113 as the
template, was carried out to mutate the recV tyrosine176 to
phenylalanine, producing pCBR115 (pRecVY176F+). To express
CwpV fragments for use as antigens (Figure 4A) cwpV repeats from
strains R20352 (type II), CDKK167 (type III), M9 (type IV) and
AY1 (type V) were amplified by PCR using KOD polymerase
(Novagen/Merck Chemicals Ltd) and primers described in Table
S1. These fragments were directionally cloned using NcoI and XhoI
into pET28a E. coli expression vector then transformed into
TOP10 E. coli (Invitrogen) to generate plasmids pCBR069-072
described in Table S2. To clone the cwpV genes from strains of
unknown genomic sequence, genomic DNA was digested
overnight at 37uC with AseI (NEB) and then ligated overnight at
16uC using T4 ligase (NEB). Inverse PCR using primers NF401
and NF654 was carried out and amplification products were
cloned into pCR4-TOPO (Invitrogen). pCBR044, containing the
full-length cwpV gene from 630 under the control of the cwp2
promoter within the pMTL960 backbone [19], was modified to
contain a 59 XhoI site and strep-tag II (WSHPQFEK) encoding
sequence by inverse PCR, generating the C. difficile strep-tagged
630 CwpV expression plasmid pCBR080 (pOEI). The cwpV genes
from R20352, CDKK167, M9 and AY1 were amplified with the
primers described in Table S1 and cloned in place of the 630 gene
in pCBR080 to create plasmids pCBR105-107 and 109 (pOEII-V)
(Table S2). Successful construction of recombinant plasmids was
always confirmed by DNA sequencing (GATC Biotech).
Conjugation into C. difficile
Plasmids were transformed into E. coli CA434 and then
conjugated into C. difficile as described previously [40] using
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21) to select for pMTL960-based plasmids
and cycloserine (250 mg ml
21) to counter-select for E. coli.
Purification of recombinant CwpV protein and
generation of antibodies
Plasmids pCBR069-072 expressing repeat types II–V were
transformed into E. coli Rosetta (Novagen/Merck Chemicals Ltd)
and grown overnight at 37uC in Overnight Express media
(Novagen/Merck Chemicals Ltd). Bacteria were collected, lysed
using BugBuster (Novagen/Merck Chemicals Ltd) and the His-
tagged fusion proteins purified by affinity chromatography using
Ni-NTA agarose (Qiagen). Following purification, proteins were
dialysed into 10 mM HEPES 150 mM NaCl. Antisera to the
proteins were generated in rabbits using a commercial service
(Covalab, Cambridge, UK). Anti-CwpVNter and anti-CwpVrptI
were described previously [19].
S-layer extraction, SDS-PAGE and western
immunoblotting
C. difficile cultures were grown overnight, harvested by
centrifugation and S-layer extracts were prepared using low pH
glycine incubation as described previously [7]. Proteins in the S-
layer extracts were subjected to SDS-PAGE and western blotting
according to standard protocols. All rabbit primary anti-CwpV
antibodies (anti-CwpVNter, anti-CwpVrptI, anti-CwpVrptII, anti-
CwpVrptIII, anti-CwpVrptIV and anti- CwpVrptV) were used at
1/5000 dilution, followed by anti-rabbit-HRP (Dako Cytomation)
at 1/2000 dilution. Signal was detected using SuperSignalH West
Pico Chemiluminescent Substrate (Pierce).
Immunocytochemistry
C. difficile cells from liquid culture were washed with PBS then
fixed in 8% formaldehyde, which was quenched with 20 mM
NH4Cl for 15 min prior to staining. Washed cell suspensions were
re-suspended in 40 ml 1% BSA in PBS containing 1/20 dilutions
of rabbit primary antibodies (anti-CwpVNter, anti-CwpVrptI,
anti-CwpVrptII, anti-CwpVrptIII, anti-CwpVrptIV and anti-
CwpVrptV) for 45 min. Bacteria were then washed and incubated
with 1/40 anti-rabbit-rhodamine red-X (Jackson ImmunoRe-
search) in the dark for 45 min. Bacteria were washed with PBS
and dH20 then allowed to air dry onto a microscope slide.
Coverslips were mounted using ProLong gold anti-fade mounting
reagent (Invitrogen) and allowed to set overnight. Bacteria were
visualised using a Nikon Eclipse E600 microscope fitted with a
Nikon DMX1200 camera.
N-terminal sequencing
S-layer extracts were separated on 10% SDS-PAGE gels and
transferred to a PVDF membrane. The membrane was washed in
water for 10 min, stained in 0.1% Coomassie Blue R in 50%
MeOH for 5 min. After destaining in 50% MeOH, 10% acetic
acid (365 min with rocking) and washing in water (365 min with
rocking) the membrane was allowed to dry thoroughly. N-terminal
sequencing by Edman degradation was then carried (PNAC
Facility, Department of Biochemistry, University of Cambridge).
C. difficile S-layer extract streptactin binding/elution
assay
StrepTactin resin (Novagen) was used according to manufactur-
ers’ instructions. Briefly, resin was washed with dH2O, equilibrat-
ed with wash buffer (150 mM NaCl, 100 mM Tris-HCl, 1 mM
EDTA, pH 8.0) and mixed with S-layer extract. The mixture was
incubated overnight at 4uC with rotation. The next day the resin
was washed with wash buffer to remove non-specifically bound
proteins. Elution buffer (150 mM NaCl, 100 mM Tris-HCl,
1 mM EDTA, 2.5 mM desthiobiotin, pH 8.0) was then used to
elute strep-tagged proteins. All fractions were collected for analysis
using SDS-PAGE and Coomassie staining.
Visualization of C. difficile colony morphology
For macroscopic visualization of C. difficile colony morphology
strains were grown on BHI agar (Oxoid) for 5 days from an
appropriate C. difficile inoculum such that isolated colonies grew on
the plate. Plates were then scanned using a flat-bed scanner to
record images of the colonies. For microscopic visualization of C.
difficile colony morphology, cultures taken from a 24-hour old
colony were inoculated directly on to glass-bottomed dishes
(MatTek corporation). Anaerobic BHI 0.7% agar at 40uC was
then carefully poured over the glass to cover the dish and allowed
to set. C. difficile was grown between the glass and the agar for 3
days. Dishes were removed and images taken using a Zeiss
Axiovert 200 widefield microscope at FILM, Imperial College
London. Microscope images were analysed using Volocity 5.3.2
software (Improvision).
Supporting Information
Figure S1 Sequence alignments of the C-terminal repeats in
CwpV types I–V. (A) The nine type I repeats in strain 630 CwpV.
(B) The eight type II repeats in strain R20352 CwpV. (C) The six
type III repeats in strain CDKK167 CwpV. (D) C. difficile strains
M9 and AY1 encode CwpV with mosaics of type III and type IV
or V repeats. A cartoon representations of these mosaic CwpV
proteins is shown above a ClustalW2 multiple sequence alignment
of all type III repeats. (E) The seven type IV repeats in strain M9
CwpV. (F) The five type V repeats in strain of AY1 CwpV. The
sequences of all repeats with a type were aligned using ClustalW2
and are shown in color, corresponding to the blocks in the cartoon,
with the exception of type II repeats which are shown in black
instead of yellow.
(PDF)
Figure S2 CwpV expression in C. difficile does not affect flagellar
expression or swimming motility. (A) C. difficile strains were
analyzed for FliC expression based on a published protocol [1]. C.
difficile FliC expression from the panel of strains with varying levels
of CwpV expression was assessed by SDS-PAGE and Coomassie
staining, with 630 FliC running at ,33 kDa. Lanes 1: WT, 2:
DcwpV, 3: pOE Nter, 4–8: pOE I-V, 9: DrecVON, 10: DrecVOFF. (B)
To assess swimming motility of C. difficile strains, BHI containing
0.175% agar was inoculated to a defined depth with C. difficile
from overnight liquid cultures. Tubes were incubated overnight
then photographed to document motility. Tubes are numbered in
the same way as the lanes in A. All cultures appeared to be equally
motile.
(TIF)
Table S1 Primers used in this study.
(DOC)
Table S2 Plasmids used in this study.
(DOC)
Table S3 Genetically modified C. difficile strains used in this
study.
(DOC)
Text S1 References for Figure S2 and Tables S2 and S3.
(RTF)
C. difficile Aggregation-Promoting Factor CwpV
PLoS Pathogens | www.plospathogens.org 13 April 2011 | Volume 7 | Issue 4 | e1002024Acknowledgments
We thank Alexandra Shaw, Zoe Seager and Marcin Dembek for excellent
technical assistance and for helpful discussions, Brendan Wren, Stephanie
d’Arc and Deirdre Ni Eidhin for bacterial strains and Dr Graham Joyce
and the FILM facility at Imperial College London and for advice on
microscopic imaging.
Author Contributions
Conceived and designed the experiments: NFF CBR JEE LdlR RPF.
Performed the experiments: CBR JEE LdlR RPF. Analyzed the data: CBR
JEE LdlR RPF NFF. Wrote the paper: CBR RPF NFF.
References
1. McFarland LV (2008) Antibiotic-associated diarrhea: epidemiology, trends and
treatment. Future Microbiol 3: 563–578.
2. Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and
role in disease. Clin Microbiol Rev 18: 247–263.
3. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, et al. (2010) The
role of toxin A and toxin B in Clostridium difficile infection. Nature 467: 711–713.
4. Lyras D, O’Connor JR, Howarth PM, Sambol SP, Carter GP, et al. (2009)
Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176–1179.
5. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, et al. (2010) The
changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23:
529–549.
6. Sleytr UB, Egelseer EM, Ilk N, Pum D, Schuster B (2007) S-Layers as a basic
building block in a molecular construction kit. FEBS J 274: 323–334.
7. Calabi E, Ward S, Wren B, Paxton T, Panico M, et al. (2001) Molecular
characterization of the surface layer proteins from Clostridium difficile.M o l
Microbiol 40: 1187–1199.
8. Kirby JM, Ahern H, Roberts AK, Kumar V, Freeman Z, et al. (2009) Cwp84, a
surface-associated cysteine protease, plays a role in the maturation of the surface
layer of Clostridium difficile. J Biol Chem 284: 34666–34673.
9. Dang TH, Riva Lde L, Fagan RP, Storck EM, Heal WP, et al. (2010) Chemical
probes of surface layer biogenesis in Clostridium difficile. ACS Chem Biol 5:
279–285.
10. Fagan RP, Albesa-Jove D, Qazi O, Svergun DI, Brown KA, et al. (2009)
Structural insights into the molecular organization of the S-layer from Clostridium
difficile. Mol Microbiol 71: 1308–1322.
11. Calabi E, Fairweather N (2002) Patterns of sequence conservation in the S-layer
proteins and related sequences in Clostridium difficile. J Bacteriol 184: 3886–3897.
12. Kato H, Yokoyama T, Arakawa Y (2005) Typing by sequencing the slpA gene of
Clostridium difficile strains causing multiple outbreaks in Japan. J Med Microbiol
54: 167–171.
13. Karjalainen T, Saumier N, Barc M-C, Delmee M, Collignon A (2002) Clostridium
difficile genotyping based on slpA variable region in S-layer gene sequence: an
alternative to serotyping. J Clin Microbiol 40: 2452–2458.
14. Eidhin D, Ryan A, Doyle R, Walsh JB, Kelleher D (2006) Sequence and
phylogenetic analysis of the gene for surface layer protein, slpA, from 14 PCR
ribotypes of Clostridium difficile. J Med Microbiol 55: 69–83.
15. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, et al. (2006) The
multidrug-resistant human pathogen Clostridium difficile has a highly mobile,
mosaic genome. Nat Genet 38: 779–786.
16. Wright A, Wait R, Begum S, Crossett B, Nagy J, et al. (2005) Proteomic analysis
of cell surface proteins from Clostridium difficile. Proteomics 5: 2443–2452.
17. Emerson JE, Stabler RA, Wren BW, Fairweather NF (2008) Microarray analysis
of the transcriptional responses of Clostridium difficile to environmental and
antibiotic stress. J Med Microbiol 57: 757–764.
18. Wright A, Drudy D, Kyne L, K. B, Fairweather NF (2008) Immunoreactive cell
wall proteins of Clostridium difficile identified by human sera. J Med Microbiol 57:
750–756.
19. Emerson JE, Reynolds CB, Fagan RP, Shaw HA, Goulding D, et al. (2009) A
novel genetic switch controls phase variable expression of CwpV, a Clostridium
difficile cell wall protein. Mol Microbiol 74: 541–556.
20. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, et al. (2010) The
ClosTron: Mutagenesis in Clostridium refined and streamlined. J Microbiol
Methods 80: 49.
21. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, et al. (2006)
Comparative phylogenomics of Clostridium difficile reveals clade specificity and
microevolution of hypervirulent strains. J Bacteriol 188: 7297–7305.
22. Shapiro JA (1995) The significances of bacterial colony patterns. Bioessays 17:
597–607.
23. Varga JJ, Nguyen V, O’Brien DK, Rodgers K, Walker RA, et al. (2006) Type IV
pili-dependent gliding motility in the Gram-positive pathogen Clostridium
perfringens and other clostridia. Mol Microbiol 62: 680–694.
24. Janvilisri T, Scaria J, Thompson AD, Nicholson A, Limbago BM, et al. (2009)
Microarray identification of Clostridium difficile core components and divergent
regions associated with host origin. J Bacteriol 191: 3881–3891.
25. Kuboniwa M, Amano A, Hashino E, Yamamoto Y, Inaba H, et al. (2009)
Distinct roles of long/short fimbriae and gingipains in homotypic biofilm
development by Porphyromonas gingivalis. BMC Microbiol 9: 105.
26. Corrigan RM, Rigby D, Handley P, Foster TJ (2007) The role of Staphylococcus
aureus surface protein SasG in adherence and biofilm formation. Microbiology
153: 2435–2446.
27. Huang YJ, Liao HW, Wu CC, Peng HL (2009) MrkF is a component of type 3
fimbriae in Klebsiella pneumoniae. Res Microbiol 160: 71–79.
28. Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, et al. (2009)
Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder
state, spore-mediated transmission, and severe disease in immunocompromised
hosts. Infect Immun 77: 3661–3669.
29. Macfarlane S, Dillon JF (2007) Microbial biofilms in the human gastrointestinal
tract. J Appl Microbiol 102: 1187–1196.
30. Douce G, Goulding D (2010) Refinement of the hamster model of Clostridium
difficile disease. Methods Mol Biol 646: 215–227.
31. Steele J, Feng H, Parry N, Tzipori S (2009) Piglet models of acute or chronic
Clostridium difficile illness. J Infect Dis 201: 428–434.
32. Thomas CM, Nielsen KM (2005) Mechanisms of, and barriers to, horizontal
gene transfer between bacteria. Nat Rev Microbiol 3: 711–721.
33. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, et al. (2010)
Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc
Natl Acad Sci U S A 107: 7527–7532.
34. Lemee L, Bourgeois I, Ruffin E, Collignon A, Lemeland JF, et al. (2005)
Multilocus sequence analysis and comparative evolution of virulence-associated
genes and housekeeping genes of Clostridium difficile. Microbiology 151:
3171–3180.
35. van der Woude MW (2006) Re-examining the role and random nature of phase
variation. FEMS Microbiol Lett 254: 190–197.
36. Dautin N, Barnard TJ, Anderson DE, Bernstein HD (2007) Cleavage of a
bacterial autotransporter by an evolutionarily convergent autocatalytic mech-
anism. EMBO J 26: 1942–1952.
37. Brannigan JA, Dodson G, Duggleby HJ, Moody PC, Smith JL, et al. (1995) A
protein catalytic framework with an N-terminal nucleophile is capable of self-
activation. Nature 378: 416–419.
38. Sara M (2001) Conserved anchoring mechanisms between crystalline cell surface
S-layer proteins and secondary cell wall polymers in Gram-positive bacteria?
Trends Microbiol 9: 47–49.
39. Marraffini LA, DeDent AC, Schneewind O (2006) Sortases and the art of
anchoring proteins to the envelopes of Gram-positive bacteria. Microbiol Mol
Biol Rev 70: 192–221.
40. Purdy D, O’Keeffe TA, Elmore M, Herbert M, McLeod A, et al. (2002)
Conjugative transfer of clostridial shuttle vectors from Escherichia coli to Clostridium
difficile through circumvention of the restriction barrier. Mol Microbiol 46:
439–452.
41. Popoff MR, Rubin EJ, Gill DM, Boquet P (1988) Actin-specific ADP-
ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56:
2299–2306.
42. Merrigan M, Sambol S, Johnson S, Gerding DN (2003) Susceptibility of
hamsters to human pathogenic Clostridium difficile strain B1 following clindamy-
cin, ampicillin or ceftriaxone administration. Anaerobe 9: 91–95.
C. difficile Aggregation-Promoting Factor CwpV
PLoS Pathogens | www.plospathogens.org 14 April 2011 | Volume 7 | Issue 4 | e1002024